JP2021528479A5 - - Google Patents
Info
- Publication number
- JP2021528479A5 JP2021528479A5 JP2021500230A JP2021500230A JP2021528479A5 JP 2021528479 A5 JP2021528479 A5 JP 2021528479A5 JP 2021500230 A JP2021500230 A JP 2021500230A JP 2021500230 A JP2021500230 A JP 2021500230A JP 2021528479 A5 JP2021528479 A5 JP 2021528479A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl group
- pharmaceutically acceptable
- pharmaceutical composition
- substituted
- pharmaceutical product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18182186.9 | 2018-07-06 | ||
| EP18182186 | 2018-07-06 | ||
| PCT/EP2019/067127 WO2020007698A1 (en) | 2018-07-06 | 2019-06-27 | Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021528479A JP2021528479A (ja) | 2021-10-21 |
| JP2021528479A5 true JP2021528479A5 (enExample) | 2022-06-22 |
Family
ID=62874761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500230A Ceased JP2021528479A (ja) | 2018-07-06 | 2019-06-27 | ヤヌスキナーゼ阻害剤としての新規アミノ−イミダゾピリミジン誘導体およびその製薬学的用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210269447A1 (enExample) |
| EP (1) | EP3818060B1 (enExample) |
| JP (1) | JP2021528479A (enExample) |
| CN (1) | CN112384514A (enExample) |
| WO (1) | WO2020007698A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022002210A1 (zh) * | 2020-07-02 | 2022-01-06 | 南京明德新药研发有限公司 | 嘧啶并吡咯基类氘代化合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7723340B2 (en) * | 2005-01-13 | 2010-05-25 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| TWI466885B (zh) * | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| CN102712640A (zh) | 2010-01-12 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 三环杂环化合物、其组合物和应用方法 |
| EP2518070A1 (en) * | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Pyrrolotriazinone derivatives as PI3K inhibitors |
| EP2518071A1 (en) * | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
| EP2527344A1 (en) * | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
| WO2013007765A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| WO2013007768A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |
| CA2888816A1 (en) | 2012-11-01 | 2014-05-08 | Incyte Corporation | Tricyclic fused thiophene derivatives as jak inhibitors |
| CN104936959B (zh) * | 2013-03-08 | 2018-09-18 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 2,6,9-三取代嘌呤衍生物及其制备方法与应用 |
| CN110167938B (zh) * | 2017-01-11 | 2024-06-14 | 阿基利昂有限公司 | 作为Janus激酶抑制剂的新的氨基-咪唑并吡啶衍生物及其医药用途 |
-
2019
- 2019-06-27 WO PCT/EP2019/067127 patent/WO2020007698A1/en not_active Ceased
- 2019-06-27 US US17/257,905 patent/US20210269447A1/en not_active Abandoned
- 2019-06-27 JP JP2021500230A patent/JP2021528479A/ja not_active Ceased
- 2019-06-27 EP EP19736624.8A patent/EP3818060B1/en active Active
- 2019-06-27 CN CN201980045057.4A patent/CN112384514A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529370A5 (enExample) | ||
| RU2019125177A (ru) | Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение | |
| RU2472509C2 (ru) | Способ лечения артрита | |
| JP2012532112A5 (enExample) | ||
| JP2024063143A5 (enExample) | ||
| JP2021525729A5 (enExample) | ||
| JP2013545730A5 (enExample) | ||
| HRP20171848T1 (hr) | Upotreba malononitrilamida za neuropatsku bol | |
| RU2019121667A (ru) | Аминопиразолы в качестве селективных ингибиторов янус-киназы | |
| JP2014502641A5 (enExample) | ||
| JP2020504186A5 (enExample) | ||
| IL287470B1 (en) | Derivatives of 6-methyl-6,1-dihydro-7H-pyrrolo[3,2-c]pyridin-7-one or of an acceptable pharmaceutical salt thereof and pharmaceutical preparations containing them. | |
| JP2023512664A5 (enExample) | ||
| JPWO2019160057A5 (enExample) | ||
| RU2015112914A (ru) | Бензимидазолы в качестве активных агентов для центральной нервной системы | |
| JP2015500223A5 (enExample) | ||
| MX2011010732A (es) | Pirimidinas sustituidas por imidazol utiles en el tratamiento de trastornos relacionados con glucogeno sintasa cinasa 3 como la enfermedad de alzheimer. | |
| JP2025516005A5 (enExample) | ||
| JP2022550919A5 (enExample) | ||
| JP2022116304A (ja) | 血液がんの治療のためのＰＰＡＲγアゴニスト | |
| US20220096475A1 (en) | Method for treating sarcoidosis-associated pulmonary hypertension | |
| US20220047594A1 (en) | Method for treating interstitial lung disease | |
| JP2023553253A5 (enExample) | ||
| JP2023552838A5 (enExample) | ||
| CN107137417B (zh) | 一种用于治疗恶病质的药物组合物及其应用 |